GCTK - CIK 0001506983
The table below shows GlucoTrack, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$4.05M | -$2.94M | -$2.94M | -$1.31M | -$1.26M | -$933.00K |
| Capital expenditure | - | $9.00K | $59.00K | - | - | - |
| Investing cash flow | - | -$9.00K | -$59.00K | - | - | - |
| Dividends paid | - | - | - | - | - |
GlucoTrack, Inc. reported operating cash flow of -$15.24M for fiscal year 2025. That is down 22.0% from -$12.49M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.31M (FY 2016) to -$15.24M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $591.00K | $6.39M | - | - | - | - |